MedTech Dive July 20, 2021
Susan Kelly

Dive Brief:

  • After a sluggish first quarter, investment in medical device makers roared back in April through June to hit $8.2 billion, with early-stage startups among the biggest beneficiaries, according to a new report from CB Insights, whose research focuses on equity rounds to private healthcare companies.
  • Late-stage funding kept pace with the prior quarter: Robot manufacturer CMR Surgical’s $600 million round and portable dialysis system maker Quanta Dialysis Technologies’ $245 million Series D deal led the category.
  • Diabetes tech developers Fractyl Health and CeQur and pathology software startups CellsVision, Aiforia and PathAI also garnered fresh backing from investors.

Dive Insight:

The global healthcare sector attracted equity investment throughout the pandemic, and it is still pouring in. The...

Today's Sponsors

Transcarent
SalesSparx
Canton & Company

Today's Sponsors

Oscar
Curation Health

Today's Sponsor

TripleTree

 
Topics: Investments, Medical Devices, Survey / Study, Technology, Trends
American Healthcare REIT Completes $4.2B M&A, Eyes IPO Next
6 private equity deals to know
Private equity firm Siris Capital in talks to acquire cybersecurity firm Radware, sources say
Highgate Capital Investments, Aurora Health Network to Buy DigitalBridge’s Health Care Portfolio for $3.2B
Dental care company quip lands $100M in Series B funding and other digital health deals